Atlas Trials

Neoplasms, Head and Neck

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Neoplasms, Head and Neck

RecordFirmDate
Study of PDS0101 and Pembrolizumab Combination I/O in Subjects With HPV16 + Recurrent and/or Metastatic HNSCC (NCT04260126)PDS Biotechnology Corp.2021-03-29
Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT04428333)GlaxoSmithKline2020-08-12
Study of GSK3359609 and Pembrolizumab in Programmed Death Receptor 1-ligand 1 (PD-L1) Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT04128696)GlaxoSmithKline2019-11-21
Head and Neck Cancer in Children: A Retrospective Study (NCT02557048)Assiut University2019-01-10
Manual Therapy and Use of the Dynasplint for Trismus in Patients With Head and Neck Cancer (NCT03178110)University of Alberta2018-10-04
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) (NCT02573493)Washington University School of Medicine2016-04-13
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma (NCT02296684)Washington University School of Medicine2015-03-25
Safety Study of SEA-CD40 in Cancer Patients (NCT02376699)Seagen Inc.2015-02-28
Change in Symptom Clusters in HNC Patients (NCT03356093)Taipei Medical University2015-01-01
Normalcy of Food Intake in Head and Neck Cancer Patients (NCT01110980)Radboud University Medical Center2010-03-01
Phase I Chemoprevention Trial With Green Tea Polyphenon E & Erlotinib in Patients With Premalignant Lesions of the Head & Neck (NCT01116336)Emory University2010-03-01
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer (NCT00798655)Robert Ferris2007-11-01
Phase 2 Study of GSK1363089 (Formerly XL880) in Adults With Squamous Cell Cancer of the Head and Neck (NCT00725764)GlaxoSmithKline2007-08-27
Study Of Adjuvant Lapatinib In High-Risk Head And Neck Cancer Subjects After Surgery (NCT00424255)GlaxoSmithKline2006-12-01
Lapatinib Versus Placebo Given Concurrently With Cisplatin And Radiotherapy In Patients With Unresected Head And Neck Cancer (NCT00387127)GlaxoSmithKline2006-11-01

Track Neoplasms, Head and Neck automatically

Every clearance here is in the API, with alerts when new ones post.